FINWIRES · TerminalLIVE
FINWIRES

Swiss Stocks Gain; Inflation Picks Up

By

-- The Swiss Market Index closed 0.38% higher on Tuesday, as investors took stock of the latest corporate updates and economic data releases that hit the market.

The annual inflation rate in Switzerland rose to 0.6% in April 2026 from 0.3% in the previous month, hitting its highest level since December 2024, government data showed. On a monthly basis, consumer prices were 0.3% higher, against the prior 0.2% gain and the consensus estimate of a 0.4% rise.

"The 0.3% increase compared with the previous month is due to several factors including rising prices for petrol, diesel and heating oil. Prices for air transport also recorded a price increase, as did those for international package holidays," the Federal Statistical Office said. "In contrast, prices for hotels and supplementary accommodation decreased, as did those for car rental and car sharing."

On the corporate side, Thomas Berden is set to step down as VAT Group's (VACN.SW) chief operating officer to pursue opportunities outside of the vacuum valves manufacturer. Berden will remain with the group until the early fourth quarter. At the end of the trading session, the Swiss stock added 3.21%.

Meanwhile, Geberit's (GEBN.SW) net sales declined 0.7% year over year to 873 million francs, impacted by negative currency effects of 35 million francs, while net income rose 4.5% to 196 million francs. The Swiss sanitary products and bathroom ceramics manufacturer's shares were down 0.35% at closing.

"Geberit delivered Q1 results, with margins modestly ahead of expectations and FX-adjusted growth stronger than expected. While the print is reassuring, part of the growth likely benefited from pull-forward effects and management remains cautious, noting that the impact of current geopolitical tensions is still difficult to quantify," according to analysts at AlphaValue/Baader Europe. "Overall, Q1 supports the resilience of the model, though visibility on the underlying run-rate remains limited."

Related Articles

Australia

American Electric Power CEO Says Speed to Market Key Issue in Load Connection

American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%

$AEP
Australia

MGE Energy Q1 Earnings, Revenue Rise

MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%

$MGEE
Research

Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.

$PFE